Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2020 Dec 17;39:287. doi: 10.1186/s13046-020-01789-3

Correction to: New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells

Cristina Alexandra Ciocan-Cartita 1,#, Ancuta Jurj 1,#, Oana Zanoaga 1, Roxana Cojocneanu 1, Laura-Ancuta Pop 1, Alin Moldovan 1, Cristian Moldovan 2, Alina Andreea Zimta 2, Lajos Raduly 1, Cecilia Pop-Bica 1, Mihail Buse 2, Liviuta Budisan 1, Piroska Virag 3, Alexandru Irimie 4,5, Sandra Martha Gomes Dias 6, Ioana Berindan-Neagoe 1,7,, Cornelia Braicu 1
PMCID: PMC7745496  PMID: 33327949

Correction to: J Exp Clin Cancer Res 39, 241 (2020)

https://doi.org/10.1186/s13046-020-01736-2

Following publication of the original article [1], the authors identified an error in the author name of Sandra Martha Gomes Dias.

The incorrect author name is: Sandra Martha Gomez Diaz

The correct author name is: Sandra Martha Gomes Dias

The author group has been updated above, and the original article has been corrected. No further changes were made to the article.

Footnotes

Cristina Alexandra Ciocan-Cartita and Ancuta Jurj contributed equally to this work.

Reference

  • 1.Ciocan-Cartita CA, et al. New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells. J Exp Clin Cancer Res. 2020;39:241. doi: 10.1186/s13046-020-01736-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES